Related Experiment Video
Updated: Jul 5, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Unlicensed/Off-Label Drug Prescriptions at Hospital Discharge in Children: An Observational Study Using Routinely
Elham Jaberi1, Inesse Boussaha2, Xavier Dode3
1UMR CNRS 5558, Laboratoire de Biométrie et Biologie Humaine, Équipe Évaluation et Modélisation des Effets Thérapeutiques, rue Guillaume-Paradin, BP8071, CEDEX 08, F-69376 Lyon, France.
Insights
Nearly 40% of pediatric hospital discharge prescriptions in France were unlicensed or off-label (UL/OL). Younger children and those with more medications were more likely to receive UL/OL prescriptions, increasing drug-related problem risks.
Area of Science:
- Pediatric Pharmacology
- Drug Safety
- Health Outcomes Research
Background:
- Unlicensed and off-label (UL/OL) prescriptions are linked to increased drug-related problems.
- Limited data exists on the prevalence of UL/OL drug use at hospital discharge.
- This study addresses the gap in understanding UL/OL prescription patterns in pediatric patients upon discharge.
Purpose of the Study:
- To determine the prevalence of unlicensed and off-label (UL/OL) drugs in outpatient prescriptions at pediatric hospital discharge.
- To identify characteristics and predictors associated with UL/OL prescriptions in children.
Main Methods:
- Retrospective analysis of routinely collected health data from pediatric hospital discharges (2014-2016).
- Utilized French industry-independent formulary Thériaque (summaries of product characteristics) to define licensed labeling.
- Described UL/OL prescription characteristics and analyzed predictors.
Main Results:
- 2536 prescriptions from 479 children were analyzed.
- Off-label (OL) prescriptions were 39.2% and unlicensed (UL) prescriptions were 2.3%, with 74% of children receiving at least one UL/OL drug.
- Younger age and a higher number of prescribed drugs were significant predictors of UL/OL prescriptions.
Conclusions:
- Approximately 40% of pediatric hospital discharge prescriptions in France involve unlicensed or off-label (UL/OL) medications.
- The high prevalence highlights potential risks and the need for careful monitoring in pediatric pharmacotherapy.
- Younger children and those with polypharmacy represent a vulnerable group for UL/OL prescribing.
Background:
Unlicensed and off-label (UL/OL) prescriptions have been associated with an increased risk of drug-related problems. Data of their prevalence at hospital discharge remain insufficient. We aimed to describe the prevalence of UL/OL drugs in outpatient prescriptions at discharge in children.
Methods:
We conducted a retrospective study using the routinely collected health data of children at discharge from 2014 to 2016. The primary reference source for determining licensed labelling was the summaries of product characteristics (SPCs) in a French industry-independent formulary named Thériaque. We described the characteristics of UL/OL prescriptions at discharge and looked for predictors of UL/OL prescriptions.
Results:
We included 2536 prescriptions of 479 children. Licensed, OL, and UL prescriptions accounted for 58.6% (95% CI: 56.7-60.5), 39.2% (95% CI: 37.3-41.1), and 2.3% (95% CI: 1.7-2.9), respectively. A total of 323 (74%) children received at least one UL/OL drug. Among the licensed drugs, bronchodilators (8.8%) and analgesics (8.6%), and among the OL drugs, antibiotics (2.8%), were the most prescribed. The younger age of the children and higher number of drugs they received increased the probability of UL/OL prescriptions (unadjusted p-value of ≤0.05).
Conclusion:
The prevalence of UL/OL prescriptions is about 40% at discharge from a pediatric university hospital in France.
Related Concept Videos
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Factors Affecting Drug Response: Overview
Discharge Summary Forms
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Drug Classes and Categories

